1. Home
  2. MLEC vs XAIR Comparison

MLEC vs XAIR Comparison

Compare MLEC & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$8.30

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.38

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
XAIR
Founded
2008
2011
Country
Cayman Islands
United States
Employees
72
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MLEC
XAIR
Price
$8.30
$0.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
19.9K
201.0K
Earning Date
05-12-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.09
EPS
N/A
N/A
Revenue
N/A
$3,705,000.00
Revenue This Year
$20.42
$122.00
Revenue Next Year
$30.00
$58.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
219.67
52 Week Low
$0.21
$0.15
52 Week High
$23.22
$3.78

Technical Indicators

Market Signals
Indicator
MLEC
XAIR
Relative Strength Index (RSI) 54.89 35.16
Support Level $8.09 N/A
Resistance Level $9.23 $0.59
Average True Range (ATR) 0.89 0.04
MACD 0.11 -0.00
Stochastic Oscillator 62.09 14.53

Price Performance

Historical Comparison
MLEC
XAIR

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: